Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs）

NCT06801119 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus
Scleroderma
Rheumatoid Arthritis

Interventions

DRUG: HN2301 injection

Sponsor

Shenzhen MagicRNA Biotechnology Co., Ltd

Collaborators

[object Object]